SAFGANDO
LIVE

Serial Number

98381206

Owner

Renibus Therapeutics, Inc.

Attorney

Brandon P. Leahy

Filing Date

Jan 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SAFGANDO Trademark

Serial Number: 98381206

SAFGANDO is a trademark filed by Renibus Therapeutics, Inc. on January 29, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Renibus Therapeutics, Inc. (8 trademarks)

181 Grand Ave, Suite 225
Southlake, TX 76092

Entity Type: 03

Trademark Details

Filing Date

January 29, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 2, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 2, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 2, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 2, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 30, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2024 NWOS
NEW APPLICATION ENTERED
Jan 29, 2024 NWAP